{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Innospec, Inc.
Innospec, Inc. Hits 52-Week Low at USD 72.03 Amid Significant Decline
Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and a conservative financial structure, but faces challenges in profitability and growth.
Innospec, Inc. Experiences Revision in Stock Evaluation Amid Competitive Market Landscape
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation metrics, including a P/E ratio of 14 and a notable dividend yield of 787.74%. Despite competitive financial indicators, the company has underperformed compared to the S&P 500, indicating market challenges.
Innospec, Inc. Hits New 52-Week Low at USD 72.33
Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to outperform market benchmarks.
Innospec, Inc. Hits 52-Week Low at USD 72.74 Amid Declining Performance
Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, shows a high dividend yield and a low debt-to-equity ratio, but has struggled with flat financial results and underperformance compared to the S&P 500.
Is Innospec, Inc. overvalued or undervalued?
As of October 24, 2025, Innospec, Inc. is fairly valued with a P/E ratio of 14 and an EV to EBITDA of 10.31, but has underperformed the S&P 500 with a year-to-date return of -30.67%.
Innospec, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Metrics
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showcasing a P/E ratio of 14 and a strong dividend yield of 787.74%. Despite recent performance challenges, its financial indicators suggest competitive positioning within the industry compared to peers.
Is Innospec, Inc. overvalued or undervalued?
As of October 24, 2025, Innospec, Inc. is fairly valued with a P/E ratio of 14 and an EV to EBITDA of 10.31, but has underperformed the market with a year-to-date return of -30.67%.
Is Innospec, Inc. overvalued or undervalued?
As of October 24, 2025, Innospec, Inc. is fairly valued with a P/E ratio of 14 and an EV to EBITDA of 10.31, but has underperformed the S&P 500 with a return of -30.17% over the past year.
Is Innospec, Inc. overvalued or undervalued?
As of October 17, 2025, Innospec, Inc. has an attractive valuation grade, indicating it may be undervalued with a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, making it a potential buying opportunity despite a year-to-date return of -32.69%.
Innospec, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation metrics, showing a P/E ratio of 14 and a PEG ratio of 0.82. Despite competitive positioning against peers, Innospec has experienced declines in year-to-date and one-year returns compared to the S&P 500.
Is Innospec, Inc. overvalued or undervalued?
As of October 17, 2025, Innospec, Inc. is considered undervalued with a P/E ratio of 14, a PEG ratio of 0.82, and an EV to EBITDA ratio of 10.31, despite a year-to-date return of -32.69% that underperforms the S&P 500's 13.30%.
Is Innospec, Inc. overvalued or undervalued?
As of October 17, 2025, Innospec, Inc. is considered undervalued with a favorable valuation grade, reflected by its lower P/E ratio of 14 compared to peers, a PEG ratio of 0.82, and a competitive EV to EBITDA ratio of 10.31, despite underperforming the S&P 500 with a year-to-date return of -32.69%.
Innospec, Inc. Stock Plummets to New 52-Week Low of $73.58
Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled with consistent performance compared to the S&P 500.
Innospec, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has experienced a decline in stock price and performance compared to the S&P 500. Technical indicators suggest a bearish sentiment, with mixed signals in the short term, reflecting the challenges the company faces in the current market.
Innospec, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape
Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation, showcasing a P/E ratio of 14 and a price-to-book value of 2.04. Key financial metrics indicate operational efficiency and solid profitability, positioning Innospec favorably compared to peers like Eastman Chemical Co. and Element Solutions, Inc.
Is Innospec, Inc. overvalued or undervalued?
As of October 3, 2025, Innospec, Inc. is fairly valued with a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, underperforming the S&P 500 with a year-to-date return of -28.42%.
Is Innospec, Inc. technically bullish or bearish?
As of September 9, 2025, Innospec, Inc. has shifted to a bearish trend with moderate strength, indicated by negative daily moving averages and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -25.41%.
Is Innospec, Inc. overvalued or undervalued?
As of September 10, 2025, Innospec, Inc. is considered an attractive investment due to its undervalued stock, reflected in a P/E ratio of 14 compared to the peer average of 15.68, a PEG ratio of 0.82, and a competitive EV to EBITDA ratio of 10.31, despite a year-to-date return of -25.41%.
Is Innospec, Inc. overvalued or undervalued?
As of October 15, 2023, Innospec, Inc. is considered attractive and undervalued with a P/E ratio of 15.2 and a P/B ratio of 2.1, outperforming peers like Croda International and BASF, and showing strong market sentiment.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
